Asia Pacific OTC Drug and Dietary Supplement Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Cough and Cold Products, Vitamins and Dietary Supplements, Analgesics, Gastrointestinal Products, Sleep Aids, Oral Care Products, Ophthalmic Products, Antacids, Feminine Care, and Others); Type (Branded, Generic); Form (Tablets, Capsules, Powders, Ointments, Liquid, and Others); Distribution Channel (Hospital and Retail Pharmacies, Retail Stores, Online Channels, and Others); and Country

No. of Pages: 198    |    Report Code: TIPRE00016069    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific OTC Drug and Dietary Supplement Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific OTC Drug and Dietary Supplement Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific OTC Drug and Dietary Supplement Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing Preference for Non-Prescription Drugs over Prescription Drugs
  • 5.1.2 Growing prevalence of infectious diseases
5.2 Market Opportunities
  • 5.2.1 R&D Activities by Market Players to Offer Improved OTC Drugs
5.3 Future Trends
  • 5.3.1 N/A
5.4 Impact of Drivers and Restraints

6. Asia Pacific OTC Drug and Dietary Supplement Market Regional Analysis

6.1 Asia Pacific OTC Drug and Dietary Supplement Market Overview
6.2 Asia Pacific OTC Drug and Dietary Supplement Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific OTC Drug and Dietary Supplement Market Forecast Analysis

7. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – by Product

7.1 Cough and Cold Products
  • 7.1.1 Overview
  • 7.1.2 Cough and Cold Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Vitamins and Dietary Supplements
  • 7.2.1 Overview
  • 7.2.2 Vitamins and Dietary Supplements: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Analgesics
  • 7.3.1 Overview
  • 7.3.2 Analgesics: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Gastrointestinal Products
  • 7.4.1 Overview
  • 7.4.2 Gastrointestinal Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Sleep Aids
  • 7.5.1 Overview
  • 7.5.2 Sleep Aids: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Oral Care Products
  • 7.6.1 Overview
  • 7.6.2 Oral Care Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Ophthalmic Products
  • 7.7.1 Overview
  • 7.7.2 Ophthalmic Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Antacids
  • 7.8.1 Overview
  • 7.8.2 Antacids: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Feminine Care
  • 7.9.1 Overview
  • 7.9.2 Feminine Care: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – by Type

8.1 Branded
  • 8.1.1 Overview
  • 8.1.2 Branded: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Generic
  • 8.2.1 Overview
  • 8.2.2 Generic: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – by Form

9.1 Tablets
  • 9.1.1 Overview
  • 9.1.2 Generic: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Capsules
  • 9.2.1 Overview
  • 9.2.2 Generic: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Powders
  • 9.3.1 Overview
  • 9.3.2 Generic: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Ointments
  • 9.4.1 Overview
  • 9.4.2 Generic: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Liquid
  • 9.5.1 Overview
  • 9.5.2 Generic: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10. Asia Pacific OTC Drug and Dietary Supplement Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
    • 10.1.1.1.2 China: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
    • 10.1.1.1.3 China: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
  • 10.1.1.2 India: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
    • 10.1.1.2.2 India: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
    • 10.1.1.2.3 India: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
  • 10.1.1.3 Japan: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
    • 10.1.1.3.2 Japan: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
    • 10.1.1.3.3 Japan: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
  • 10.1.1.4 Australia: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
    • 10.1.1.4.2 Australia: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
    • 10.1.1.4.3 Australia: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific OTC Drug and Dietary Supplement Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 GlaxoSmithKline plc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Sanofi
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Abbott
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 AbbVie Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Bausch Health Companies Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Bayer AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Procter & Gamble
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Novartis AG
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Reckitt Benckiser Group Plc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia Pacific OTC Drug and Dietary Supplement Market

The List of Companies - Asia Pacific OTC Drug and Dietary Supplement Market
  1. GlaxoSmithKline plc.
  2. Sanofi
  3. Johnson and Johnson Services, Inc.
  4. Abbott
  5. AbbVie Inc.
  6. Bausch Health Companies Inc.
  7. Bayer AG
  8. Procter & Gamble
  9. Novartis AG
  10. Reckitt Benckiser Group Plc
asia-pacific-otc-drug-and-dietary-supplement-market